Alliance Pharma plc (APH) — Long-term Investment Intensity
Alliance Pharma plc (APH) has a Long-term Investment Intensity of 0.4% as of December 2017. Long-term investments of GBX1.48 Million represent 0.4% of total assets of GBX336.48 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Alliance Pharma plc (APH) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Alliance Pharma plc Long-term Investment Intensity (2013–2017)
This chart shows how Alliance Pharma plc's Long-term Investment Intensity has evolved across 5 annual periods from 2013 to 2017. As of December 2017, the intensity stands at 0.4%, reflecting long-term investments of GBX1.48 Million against total assets of GBX336.48 Million GBX. Explore Alliance Pharma plc (APH) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Alliance Pharma plc (2013–2017)
The table below presents the year-by-year Long-term Investment Intensity for Alliance Pharma plc from 2013 to 2017, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Alliance Pharma plc worth.
| Year | LT Investment Intensity | LT Investments (GBX) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 0.4% | GBX1.48 Million | GBX336.48 Million | ▼ 0.0 pp |
| 2016 | 0.5% | GBX1.46 Million | GBX320.74 Million | ▼ 0.0 pp |
| 2015 | 0.5% | GBX1.47 Million | GBX292.19 Million | ▼ -0.7 pp |
| 2014 | 1.2% | GBX1.27 Million | GBX107.87 Million | ▲ +0.3 pp |
| 2013 | 0.9% | GBX976.00K | GBX106.99 Million | — |